259
Views
65
CrossRef citations to date
0
Altmetric
Review

Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors

&
Pages 1221-1240 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Nasim Ebrahimi, Maryam Akbari, Masoud Ghanaatian, Parichehr Roozbahani moghaddam, Samaneh Adelian, Marziyeh Borjian Boroujeni, Elnaz Yazdani, Amirhossein Ahmadi & Michael R. Hamblin. (2022) Development of neoantigens: from identification in cancer cells to application in cancer vaccines. Expert Review of Vaccines 21:7, pages 941-955.
Read now
Peter Pushko, Igor S. Lukashevich, Scott C. Weaver & Irina Tretyakova. (2016) DNA-launched live-attenuated vaccines for biodefense applications. Expert Review of Vaccines 15:9, pages 1223-1234.
Read now
Emily A. Voigt, Richard B. Kennedy & Gregory A. Poland. (2016) Defending against smallpox: a focus on vaccines. Expert Review of Vaccines 15:9, pages 1197-1211.
Read now
Maria Tagliamonte, Annacarmen Petrizzo, Maria Lina Tornesello, Franco M Buonaguro & Luigi Buonaguro. (2014) Antigen-specific vaccines for cancer treatment. Human Vaccines & Immunotherapeutics 10:11, pages 3332-3346.
Read now
Juan García-Arriaza & Mariano Esteban. (2014) Enhancing poxvirus vectors vaccine immunogenicity. Human Vaccines & Immunotherapeutics 10:8, pages 2235-2244.
Read now
Carmen Elena Gómez, Beatriz Perdiguero, Juan García-Arriaza & Mariano Esteban. (2013) Clinical applications of attenuated MVA poxvirus strain. Expert Review of Vaccines 12:12, pages 1395-1416.
Read now
José I. Quetglas, Liza B. John, Michael H. Kershaw, Luis Álvarez-Vallina, Ignacio Melero, Phillip K. Darcy & Cristian Smerdou. (2012) Virotherapy, gene transfer and immunostimulatory monoclonal antibodies. OncoImmunology 1:8, pages 1344-1354.
Read now
Luigi Aurisicchio & Gennaro Ciliberto. (2012) Genetic cancer vaccines: current status and perspectives. Expert Opinion on Biological Therapy 12:8, pages 1043-1058.
Read now

Articles from other publishers (57)

Heng Xia, Yun-Ru He, Xiao-Yong Zhan & Gao-Feng Zha. (2023) Mpox virus mRNA-lipid nanoparticle vaccine candidates evoke antibody responses and drive protection against the Vaccinia virus challenge in mice. Antiviral Research, pages 105668.
Crossref
Ravi Teja Chitturi Suryaprakash, Mohammad Ayman Abdulkarim Safi, Noufa Alonazi, Ahdab A. Alsieedi & Omar Kujan. 2023. Molecular Targets and Cancer Therapeutics (Part 2). Molecular Targets and Cancer Therapeutics (Part 2) 165 235 .
Miguel Hernandez-Gonzalez, Thomas Calcraft, Andrea Nans, Peter B Rosenthal & Michael Way. (2023) A succession of two viral lattices drives vaccinia virus assembly. PLOS Biology 21:3, pages e3002005.
Crossref
Sameer Elsayed, Lise Bondy & William P. Hanage. (2022) Monkeypox Virus Infections in Humans. Clinical Microbiology Reviews 35:4.
Crossref
Wen Tzuen Heng, Jia Sheng Yew & Chit Laa Poh. (2022) Nanovaccines against Viral Infectious Diseases. Pharmaceutics 14:12, pages 2554.
Crossref
Sultan Ayoub Meo, Thamir Al-Khlaiwi, Ziyad Fahad Aljofan, Aued Iaed Alanazi & Anusha Sultan Meo. (2022) Public Perceptions of the Emerging Human Monkeypox Disease and Vaccination in Riyadh, Saudi Arabia: A Cross-Sectional Study. Vaccines 10:9, pages 1534.
Crossref
Olga Vladimirovna Orlova, Dina Viktorovna Glazkova, Elena Vladimirovna Bogoslovskaya, German Alexandrovich Shipulin & Sergey Mikhailovich Yudin. (2022) Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications. Vaccines 10:9, pages 1516.
Crossref
Matthew G. Brewer, Stephanie R. Monticelli, Mary C. Moran, Benjamin L. Miller, Lisa A. Beck & Brian M. Ward. (2022) Conditions That Simulate the Environment of Atopic Dermatitis Enhance Susceptibility of Human Keratinocytes to Vaccinia Virus. Cells 11:8, pages 1337.
Crossref
Arunima Sikdar, Rupali Gupta & Evzen Boura. (2022) Reviewing Antiviral Research against Viruses Causing Human Diseases - a Structure-Guided Approach. Current Molecular Pharmacology 15:2, pages 306-337.
Crossref
Rokshana Parvin, Ahmed Ali, Abdou Nagy, Zheng Zhu, Suhui Zhao, Alok K. Paul, Hafez M. Hafez & Awad A. Shehata. (2022) Monkeypox virus: A comprehensive review of taxonomy, evolution, epidemiology, diagnosis, prevention, and control regiments so far. German Journal of Microbiology 2:2, pages 1-15.
Crossref
Akiko Eto, Norio Yamamoto & Yasuhiro Kanatani. (2021) Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain. Biology 10:11, pages 1158.
Crossref
Rakesh Kulkarni, Wen-Ching Chen, Ying Lee, Chi-Fei Kao, Shiu-Lok Hu, Hsiu-Hua Ma, Jia-Tsrong Jan, Chun-Che Liao, Jian-Jong Liang, Hui-Ying Ko, Cheng-Pu Sun, Yin-Shoiou Lin, Yu-Chiuan Wang, Sung-Chan Wei, Yi-Ling Lin, Che Ma, Yu-Chan Chao, Yu-Chi Chou & Wen Chang. (2021) Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters. PLOS ONE 16:9, pages e0257191.
Crossref
Mingyu Ye, Markus Keicher, Ivaylo Gentschev & Aladar A. Szalay. (2021) Efficient Selection of Recombinant Fluorescent Vaccinia Virus Strains and Rapid Virus Titer Determination by Using a Multi-Well Plate Imaging System. Biomedicines 9:8, pages 1032.
Crossref
Tomoki Yoshikawa, Satoshi Taniguchi, Hirofumi Kato, Naoko Iwata-Yoshikawa, Hideki Tani, Takeshi Kurosu, Hikaru Fujii, Natsumi Omura, Miho Shibamura, Shumpei Watanabe, Kazutaka Egawa, Takuya Inagaki, Satoko Sugimoto, Supranee Phanthanawiboon, Shizuko Harada, Souichi Yamada, Shuetsu Fukushi, Shigeru Morikawa, Noriyo Nagata, Masayuki Shimojima & Masayuki Saijo. (2021) A highly attenuated vaccinia virus strain LC16m8-based vaccine for severe fever with thrombocytopenia syndrome. PLOS Pathogens 17:2, pages e1008859.
Crossref
Rosangela Salerno‐Gonçalves, Wilbur H Chen, Mark J Mulligan, Sharon E Frey, Jack T Stapleton, Wendy A Keitel, Jason Bailey, Eli Sendra, Heather Hill, Robert A Johnson & Marcelo B Sztein. (2021) Vaccine‐related major cutaneous reaction size correlates with cellular‐mediated immune responses after tularaemia immunisation. Clinical & Translational Immunology 10:1.
Crossref
Linus D. Kloker, Susanne Berchtold, Irina Smirnow, Julia Beil, Andreas Krieg, Bence Sipos & Ulrich M. Lauer. (2020) Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasms. BMC Cancer 20:1.
Crossref
Ashis Debnath, Dinesh C Pathak, Ajai Lawrence D’silva, Rahul Batheja, Narayan Ramamurthy, Vikram N. Vakharia, Madhan Mohan Chellappa & Sohini Dey. (2020) Newcastle disease virus vectored rabies vaccine induces strong humoral and cell mediated immune responses in mice. Veterinary Microbiology 251, pages 108890.
Crossref
Vivian Lei, Amy J. Petty, Amber R. Atwater, Sarah A. Wolfe & Amanda S. MacLeod. (2020) Skin Viral Infections: Host Antiviral Innate Immunity and Viral Immune Evasion. Frontiers in Immunology 11.
Crossref
Anjali Gowripalan, Stewart Smith, Tijana Stefanovic & David C. Tscharke. (2020) Rapid poxvirus engineering using CRISPR/Cas9 as a selection tool. Communications Biology 3:1.
Crossref
Zoe Moodie, Stephen R. Walsh, Fatima Laher, Lucas Maganga, Michael E. Herce, Sarita Naidoo, Mina C. Hosseinipour, Craig Innes, Linda-Gail Bekker, Nicole Grunenberg, Philipp Mann, Chenchen Yu, Allan C. deCamp, Maurine D. Miner, Nicole L. Yates, Jack Heptinstall, Nonhlanhla N. Mkhize, One Dintwe, Nicole Frahm, Kristen W. Cohen, Mary Allen, Julia Hutter, Ralf Wagner, Giuseppe Pantaleo, M. Juliana McElrath, Georgia D. Tomaras, Lynn Morris, David C. Montefiori, Erica Andersen-Nissen, Glenda E. Gray, Peter B. Gilbert & James G. Kublin. (2020) Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials. PLOS Medicine 17:5, pages e1003117.
Crossref
Boris R. Minev, Elliot Lander, John F. Feller, Mark Berman, Bernadette M. Greenwood, Ivelina Minev, Antonio F. Santidrian, Duong Nguyen, Dobrin Draganov, Mehmet O. Killinc, Anna Vyalkova, Santosh Kesari, Edward McClay, Gabriel Carabulea, Francesco M. Marincola, Lisa H. Butterfield & Aladar A. Szalay. (2019) First-in-human study of TK-positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells. Journal of Translational Medicine 17:1.
Crossref
Hoan Van Ngo & Serge Mostowy. (2019) Role of septins in microbial infection. Journal of Cell Science 132:9.
Crossref
Jennifer R. Head, Ad Vos, Jesse Blanton, Thomas Müller, Richard Chipman, Emily G. Pieracci, Julie Cleaton & Ryan Wallace. (2019) Environmental distribution of certain modified live-virus vaccines with a high safety profile presents a low-risk, high-reward to control zoonotic diseases. Scientific Reports 9:1.
Crossref
Hanns-Joachim Rziha, Mathias Büttner, Melanie Müller, Ferdinand Salomon, Alena Reguzova, Dominic Laible & Ralf Amann. (2019) Genomic Characterization of Orf Virus Strain D1701-V (Parapoxvirus) and Development of Novel Sites for Multiple Transgene Expression. Viruses 11:2, pages 127.
Crossref
Lindsey R Baden, Stephen R Walsh, Michael S Seaman, Yehuda Z Cohen, Jennifer A Johnson, J Humberto Licona, Rachel D Filter, Jane A Kleinjan, Jon A Gothing, Julia Jennings, Lauren Peter, Joseph Nkolola, Peter Abbink, Erica N Borducchi, Marinela Kirilova, Kathryn E Stephenson, Poonam Pegu, Michael A Eller, Hung V Trinh, Mangala Rao, Julie A Ake, Michal Sarnecki, Steven Nijs, Katleen Callewaert, Hanneke Schuitemaker, Jenny Hendriks, Maria G Pau, Frank Tomaka, Bette T Korber, Galit Alter, Raphael Dolin, Patricia L Earl, Bernard Moss, Nelson L Michael, Merlin L Robb, Dan H Barouch, Alka Patel, Kevin Zinchuk, Alexis Liakos, Brian Engelson, Sarah Ganley, Chun Su Mei, Mark J Iampietro, Ann Cheung, Kara Brandariz, Annalena LaPorte, Anna G McNally, Jennifer Shields, Kelly A Stanley, Rebecca Dilan, Faye Stephens, Robyn Hamel, Madeline Bayne, Katherine E Yanosick, Alexander Robles, Marshall Zingg, David J Dominguez, Christy L Lavine, Jetta Garrity, Michael Rist, Fadi Ghantous, Nicholas Fredette, Karen Buleza, Raphaele Roten, Olive Yuan, Gitta Huskens, Heidi Muller, Zelda Euler, Caroline Hodin, Lorenz Scheppler, Makoto Wajima, Soniya Gadre, James Nichols, Amy Kinney & Mo Weijtens. (2018) First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector. The Journal of Infectious Diseases 218:4, pages 633-644.
Crossref
Tomoki Yoshikawa, Hikaru Fujii, Akiko Okutani, Miho Shibamura, Natsumi Omura, Kazutaka Egawa, Hirofumi Kato, Takuya Inagaki, Shizuko Harada, Souichi Yamada, Shigeru Morikawa & Masayuki Saijo. (2018) Construction and characterization of bacterial artificial chromosomes harboring the full-length genome of a highly attenuated vaccinia virus LC16m8. PLOS ONE 13:2, pages e0192725.
Crossref
Natsumi Omura, Tomoki Yoshikawa, Hikaru Fujii, Miho Shibamura, Takuya Inagaki, Hirofumi Kato, Kazutaka Egawa, Shizuko Harada, Souichi Yamada, Haruko Takeyama & Masayuki Saijo. (2018) A Novel System for Constructing a Recombinant Highly-Attenuated Vaccinia Virus Strain (LC16m8) Expressing Foreign Genes and Its Application for the Generation of LC16m8-Based Vaccines against Herpes Simplex Virus 2. Japanese Journal of Infectious Diseases 71:3, pages 229-233.
Crossref
Zong Sheng Guo, Zuqiang Liu, Magesh Sathaiah, Jiahu Wang, Roshni Ravindranathan, Eun Kim, Shaohua Huang, Thomas W. Kenniston, John C. Bell, Herbert J. ZehIIIIII, Lisa H. Butterfield, Andrea Gambotto & David L. Bartlett. (2017) Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus. Molecular Therapy - Methods & Clinical Development 7, pages 112-122.
Crossref
Marek Cyrklaff, Friedrich Frischknecht & Mikhail Kudryashev. (2017) Functional insights into pathogen biology from 3D electron microscopy. FEMS Microbiology Reviews 41:6, pages 828-853.
Crossref
Lidia Szulc-Dąbrowska, Justyna Struzik, Agnieszka Ostrowska, Maciej Guzera, Felix N. Toka, Magdalena Bossowska-Nowicka, Małgorzata M. Gieryńska, Anna Winnicka, Zuzanna Nowak & Marek G. Niemiałtowski. (2017) Functional paralysis of GM-CSF–derived bone marrow cells productively infected with ectromelia virus. PLOS ONE 12:6, pages e0179166.
Crossref
David L. Veyer, Guia Carrara, Carlos Maluquer de Motes & Geoffrey L. Smith. (2017) Vaccinia virus evasion of regulated cell death. Immunology Letters 186, pages 68-80.
Crossref
Carl Fortin, Yiping Yang & Xiaopei Huang. (2017) Monocytic myeloid-derived suppressor cells regulate T-cell responses against vaccinia virus. European Journal of Immunology 47:6, pages 1022-1031.
Crossref
J. Patrick Condreay, Thomas A. Kost & Claudia A. Mickelson. 2017. Biological Safety. Biological Safety 221 246 .
Peter Tsirikis, Sue D. Xiang, Cordelia Selomulya & Magdalena Plebanski. 2017. Nanostructures for Cancer Therapy. Nanostructures for Cancer Therapy 307 328 .
Rebecca P. Sumner, Hongwei Ren, Brian J. Ferguson & Geoffrey L. Smith. (2016) Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators. Vaccine 34:40, pages 4827-4834.
Crossref
Ji Wang, Peiyu Li, Xinyuan Chen & Mei X. Wu. (2016) Laser facilitates vaccination. Journal of Innovative Optical Health Sciences 09:01, pages 1630003.
Crossref
Hanns-Joachim Rziha, Jörg Rohde & Ralf Amann. 2016. Vaccine Technologies for Veterinary Viral Diseases. Vaccine Technologies for Veterinary Viral Diseases 177 200 .
Flavia Leite & Michael Way. (2015) The role of signalling and the cytoskeleton during Vaccinia Virus egress. Virus Research 209, pages 87-99.
Crossref
Lucas Sánchez-Sampedro, Beatriz Perdiguero, Ernesto Mejías-Pérez, Juan García-Arriaza, Mauro Di Pilato & Mariano Esteban. (2015) The Evolution of Poxvirus Vaccines. Viruses 7:4, pages 1726-1803.
Crossref
Birgit Korioth-Schmitz, Dieter Affeln, Susanne L. Simon, William M. Decaneas, Gary B. Schweon, Michael Wong & Adrian Gardner. (2015) Vaccinia Virus—Laboratory Tool with a Risk of Laboratory-Acquired Infection. Applied Biosafety 20:1, pages 6-11.
Crossref
Sarah Neidel, Carlos Maluquer de Motes, Daniel S. Mansur, Pavla Strnadova, Geoffrey L. Smith & Stephen C. Graham. (2015) Vaccinia Virus Protein A49 Is an Unexpected Member of the B-cell Lymphoma (Bcl)-2 Protein Family. Journal of Biological Chemistry 290:10, pages 5991-6002.
Crossref
Alfredo G. Torres, Jai S. Rudra & Gregg N. Milligan. 2015. Vaccinology. Vaccinology 127 151 .
Min Fang, Sanda Remakus, Felicia Roscoe, Xueying Ma & Luis J. Sigal. (2015) CD4 + T Cell Help Is Dispensable for Protective CD8 + T Cell Memory against Mousepox Virus following Vaccinia Virus Immunization . Journal of Virology 89:1, pages 776-783.
Crossref
Dan H. Barouch, Lindsey R. Baden & Raphael Dolin. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 1666 1673.e4 .
Minoru Kidokoro & Hisatoshi Shida. (2014) Vaccinia Virus LC16m8∆ as a Vaccine Vector for Clinical Applications. Vaccines 2:4, pages 755-771.
Crossref
Liang Liu, Tamara Cooper, Paul Howley & John Hayball. (2014) From Crescent to Mature Virion: Vaccinia Virus Assembly and Maturation. Viruses 6:10, pages 3787-3808.
Crossref
Inna G. Ovsyannikova, V. Shane Pankratz, Hannah M. Salk, Richard B. Kennedy & Gregory A. Poland. (2014) HLA alleles associated with the adaptive immune response to smallpox vaccine: a replication study. Human Genetics 133:9, pages 1083-1092.
Crossref
Jeffrey E. Teigler, Sanjay Phogat, Genoveffa Franchini, Vanessa M. Hirsch, Nelson L. Michael & Dan H. Barouch. (2014) The Canarypox Virus Vector ALVAC Induces Distinct Cytokine Responses Compared to the Vaccinia Virus-Based Vectors MVA and NYVAC in Rhesus Monkeys. Journal of Virology 88:3, pages 1809-1814.
Crossref
Sofiya Fedosyuk, Irina Grishkovskaya, Euripedes de Almeida RibeiroJr.Jr. & Tim Skern. (2014) Characterization and Structure of the Vaccinia Virus NF-κB Antagonist A46. Journal of Biological Chemistry 289:6, pages 3749-3762.
Crossref
Geoffrey L. Smith, Camilla T. O. Benfield, Carlos Maluquer de Motes, Michela Mazzon, Stuart W. J. Ember, Brian J. Ferguson & Rebecca P. Sumner. (2013) Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity. Journal of General Virology 94:11, pages 2367-2392.
Crossref
A.F. Rodrigues, A.S. Formas-Oliveira, V.S. Bandeira, P.M. Alves, W.S. Hu & A.S. Coroadinha. (2013) Metabolic pathways recruited in the production of a recombinant enveloped virus: Mining targets for process and cell engineering. Metabolic Engineering 20, pages 131-145.
Crossref
Jennifer A. Johnson, Dan H. Barouch & Lindsay R. Baden. (2013) Nonreplicating vectors in HIV vaccines. Current Opinion in HIV and AIDS 8:5, pages 412-420.
Crossref
Camilla T. O. Benfield, Hongwei Ren, Stuart J. Lucas, Basma Bahsoun & Geoffrey L. Smith. (2013) Vaccinia virus protein K7 is a virulence factor that alters the acute immune response to infection. Journal of General Virology 94:7, pages 1647-1657.
Crossref
Joseph A. Hollenbaugh, Peter Gee, Jonathon Baker, Michele B. Daly, Sarah M. Amie, Jessica Tate, Natsumi Kasai, Yuka Kanemura, Dong-Hyun Kim, Brian M. Ward, Yoshio Koyanagi & Baek Kim. (2013) Host Factor SAMHD1 Restricts DNA Viruses in Non-Dividing Myeloid Cells. PLoS Pathogens 9:6, pages e1003481.
Crossref
Stephen R. Walsh, Marissa B. Wilck, David J. Dominguez, Elise Zablowsky, Shringkhala Bajimaya, Lisa S. Gagne, Kelly A. Verrill, Jane A. Kleinjan, Alka Patel, Ying Zhang, Heather Hill, Aruna Acharyya, David C. Fisher, Joseph H. Antin, Michael S. Seaman, Raphael Dolin & Lindsey R. Baden. (2013) Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial. The Journal of Infectious Diseases 207:12, pages 1888-1897.
Crossref
Chunqing Guo, Masoud H. Manjili, John R. Subjeck, Devanand Sarkar, Paul B. Fisher & Xiang-Yang Wang. 2013. 421 475 .
Stephen R. Walsh, Michael S. Seaman, Lauren E. Grandpre, Cherie Charbonneau, Katherine E. Yanosick, Barbara Metch, Michael C. Keefer, Raphael Dolin & Lindsey R. Baden. (2012) Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses. Vaccine 31:1, pages 114-119.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.